Preventive effects of lactobacillus mixture on experimental E. coli urinary tract infection in infant rats

Yonsei Medical Journal

Volumn 54, Issue 2, 2013, Pages 489-493

  Lee, Jung Won ^a   Lee, Jee Hyun ^a   Sung, Sun Hee ^b   Lee, Seung Joo ^b  

^a Hallym University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

Author keywords

Cystitis; Intravesical instillation; Lactobacillus; Pyelonephritis

Indexed keywords

LACTOBACILLUS EXTRACT; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTITIS; ESCHERICHIA COLI; FECES CULTURE; HISTOPATHOLOGY; INFLAMMATION; LACTOBACILLUS; LACTOBACILLUS GASSERI; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; OPTIMAL DRUG DOSE; PYELONEPHRITIS; RAT; URINARY TRACT INFECTION; URINE CULTURE;

ANIMALS; ESCHERICHIA COLI INFECTIONS; LACTOBACILLUS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; URINARY TRACT INFECTIONS;

EID: 84873271035     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.2.489     Document Type: Article

References (26)

1. Usein CR, Damian M, Tatu-Chiţoiu D, Cǎpuşǎ C, Fǎgǎraş R, Mircescu G. Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections. Roum Arch Microbiol Immunol 2003;62:137-54.
2. Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990;12:856-72.
3. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 2006;24:28-32.
4. Reid G, Chan RC, Bruce AW, Costerton JW. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect Immun 1985;49:320-4.
5. Asahara T, Nomoto K, Watanuki M, Yokokura T. Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 2001;45:1751-60.
6. Fraga M, Scavone P, Zunino P. Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model. Antonie Van Leeuwenhoek 2005;88:25-34.
7. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infection. Microecol Ther 1995;23:32-45.
8. Uehara S, Monden K, Nomoto K, Seno Y, Kariyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J Antimicrob Agents 2006;28 Suppl 1:S30-4.
9. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011; 52:1212-7.
10. Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol 2007;22:1315-20.
11. Abad CL, Safdar N. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review. J Chemother 2009;21:243-52.
12. Matsumiya Y, Kato N, Watanabe K, Kato H. Molecular epidemiological study of vertical transmission of vaginal Lactobacillus species from mothers to newborn infants in Japanese, by arbitrarily primed polymerase chain reaction. J Infect Chemother 2002;8:43-9.
13. Martín R, Langa S, Reviriego C, Jimínez E, Marín ML, Xaus J, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 2003;143:754-8.
14. Rinne M, Kalliomaki M, Arvilommi H, Salminen S, Isolauri E. Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr 2005;147:186-91.
15. Hall MA, Cole CB, Smith SL, Fuller R, Rolles CJ. Factors influencing the presence of faecal lactobacilli in early infancy. Arch Dis Child 1990;65:185-8.
16. Sanz Y. Gut microbiota and probiotics in maternal and infant health. Am J Clin Nutr 2011;94(6 Suppl):2000S-5S.
17. Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 2004;38(6 Suppl):S107-10.
18. Lee JW, Shim YH, Lee SJ. Lactobacillus colonization status in infants with urinary tract infection. Pediatr Nephrol 2009;24:135-9.
19. Bruce AW, Chadwick P, Hassan A, VanCott GF. Recurrent urethritis in women. Can Med Assoc J 1973;108:973-6.
20. Marrie TJ, Swantee CA, Hartlen M. Aerobic and anaerobic urethral flora of healthy females in various physiological age groups and of females with urinary tract infections. J Clin Microbiol 1980;11:654-9.
21. Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE. Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998;178:446-50.
22. Kirjavainen PV, Pautler S, Baroja ML, Anukam K, Crowley K, Carter K, et al. Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol 2009;16:29-36.
23. Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl Environ Microbiol 1996;62:1958-63.
24. Zárate G, Nader-Macias ME. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol 2006;43:174-80.
25. Rodríguez JM, Martínez MI, Horn N, Dodd HM. Heterologous production of bacteriocins by lactic acid bacteria. Int J Food Microbiol 2003;80:101-16.
26. Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000;78:67-73.